Calliditas Therapeutics AB PEG Ratio

Calliditas Therapeutics AB (CALT) currently reports a PEG ratio of 49.5. That is above the Healthcare sector average of 3.22. Use the charts on this page to explore Calliditas Therapeutics AB's PEG ratio history and peer comparisons.

Calliditas Therapeutics AB's PEG ratio of 49.5 is higher than the Healthcare sector average of 3.22. That is roughly 1436.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Calliditas Therapeutics AB's market price to a fundamental measure such as earnings, sales, or book value. At 49.5, CALT can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 49.5, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 3.22. From there, open related valuation or income-statement pages for Calliditas Therapeutics AB, and consider following CALT for alerts when major investors trade the stock.

Calliditas Therapeutics AB is classified in the Healthcare sector. On PEG ratio, it currently shows 49.5 versus a sector average near 3.22. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CALT with unrelated industries.